Amanote Research
Register
Sign In
Suppression of Survivin Expression in Glioblastoma Cells by the Ras Inhibitor Farnesylthiosalicylic Acid Promotes Caspase-Dependent Apoptosis
Molecular Cancer Therapeutics
- United States
doi 10.1158/1535-7163.mct-06-0193
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
September 1, 2006
Authors
R. Blum
Publisher
American Association for Cancer Research (AACR)
Related search
Suppression of Lung Cancer Tumor Growth in a Nude Mouse Model by the Ras Inhibitor Salirasib (Farnesylthiosalicylic Acid)
Molecular Cancer Therapeutics
Cancer Research
Oncology
Survivin Selective Inhibitor YM155 Promotes Cisplatin‑induced Apoptosis in Embryonal Rhabdomyosarcoma
International Journal of Oncology
Cancer Research
Oncology
The Ras Inhibitor Farnesylthiosalicylic Acid as a Potential Therapy for Neurofibromatosis Type 1
Clinical Cancer Research
Cancer Research
Oncology
Basal Caspase Activity Promotes Migration and Invasiveness in Glioblastoma Cells
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Clinical Significance of Inhibitor of Apoptosis Protein Survivin Expression in Colorectal Cancer
Novosti Khirurgii
Surgery
Valproic Acid Inhibits the Growth of HeLa Cervical Cancer Cells via Caspase-Dependent Apoptosis
Oncology Reports
Medicine
Cancer Research
Oncology
The Novel Akt Inhibitor, Perifosine, Induces Caspase-Dependent Apoptosis and Downregulates P-Glycoprotein Expression in Multidrug-Resistant Human T-Acute Leukemia Cells by a JNK-dependent Mechanism
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Caspase-Dependent Suppression of Type I Interferon Signaling Promotes KSHV Lytic Replication
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Inhibition of Contact Sensitivity by Farnesylthiosalicylic Acid-Amide, a Potential Rap1 Inhibitor
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
